Global Satralizumab Production, Demand and Key Producers, 2022-2028
Satralizumab is a recombinant humanized monoclonal antibody targeted against human interleukin-6 (IL-6) receptors, similar to tocilizumab, which is produced in Chinese hamster ovary cells and based on an IgG2 framework. Satralizumab is used in the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune inflammatory disorder of the central nervous system (CNS) involving demyelinating lesions in the optic nerve, spinal cord, brainstem, and cerebrum.
This report studies the global Satralizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Satralizumab, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Satralizumab that contribute to its increasing demand across many markets.
The global Satralizumab market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Satralizumab total production and demand, 2017-2028, (K Units)
Global Satralizumab total production value, 2017-2028, (USD Million)
Global Satralizumab production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Satralizumab consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Satralizumab domestic production, consumption, key domestic manufacturers and share
Global Satralizumab production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Satralizumab production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Satralizumab production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Satralizumab market based on the following parameters – headquarters, production locations, products portfolio, Satralizumab revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Satralizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Satralizumab Market, By Region:
1. How big is the global Satralizumab market?
2. What is the demand of the global Satralizumab market?
3. What is the year over year growth of the global Satralizumab market?
4. What is the production and production value of the global Satralizumab market?
5. Who are the key producers in the global Satralizumab market?
6. What are the growth factors driving the market demand?
This report studies the global Satralizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Satralizumab, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Satralizumab that contribute to its increasing demand across many markets.
The global Satralizumab market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Satralizumab total production and demand, 2017-2028, (K Units)
Global Satralizumab total production value, 2017-2028, (USD Million)
Global Satralizumab production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Satralizumab consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Satralizumab domestic production, consumption, key domestic manufacturers and share
Global Satralizumab production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Satralizumab production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Satralizumab production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Satralizumab market based on the following parameters – headquarters, production locations, products portfolio, Satralizumab revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Satralizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Satralizumab Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Solution
- Injection
- Treating Neuromyelitis Optica
- Prevention of Neuromyelitis Optica
- Others
- Hoffmann La Roche
- Genentech Inc.
- CHUGAI PHARMACEUTICAL CO.,LTD.
1. How big is the global Satralizumab market?
2. What is the demand of the global Satralizumab market?
3. What is the year over year growth of the global Satralizumab market?
4. What is the production and production value of the global Satralizumab market?
5. Who are the key producers in the global Satralizumab market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Satralizumab Introduction
1.2 World Satralizumab Supply & Forecast
1.2.1 World Satralizumab Production Value (2017 & 2021 & 2028)
1.2.2 World Satralizumab Production (2017-2028)
1.2.3 World Satralizumab Pricing Trends (2017-2028)
1.3 World Satralizumab Production by Region
1.3.1 World Satralizumab Production Value by Region (2017-2028)
1.3.2 World Satralizumab Production by Region (2017-2028)
1.3.3 World Satralizumab Average Price by Region (2017-2028)
1.3.4 North America Satralizumab Production (2017-2028)
1.3.5 Europe Satralizumab Production (2017-2028)
1.3.6 Japan Satralizumab Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Satralizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Satralizumab Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Satralizumab Demand (2017-2028)
2.2 World Satralizumab Consumption by Region
2.2.1 World Satralizumab Consumption by Region (2017-2022)
2.2.2 World Satralizumab Consumption Forecast by Region (2023-2028)
2.3 United States Satralizumab Consumption (2017-2028)
2.4 China Satralizumab Consumption (2017-2028)
2.5 Europe Satralizumab Consumption (2017-2028)
2.6 Japan Satralizumab Consumption (2017-2028)
2.7 South Korea Satralizumab Consumption (2017-2028)
2.8 ASEAN Satralizumab Consumption (2017-2028)
2.9 India Satralizumab Consumption (2017-2028)
3 WORLD SATRALIZUMAB MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Satralizumab Production Value by Manufacturer (2017-2022)
3.2 World Satralizumab Production by Manufacturer (2017-2022)
3.3 World Satralizumab Average Price by Manufacturer (2017-2022)
3.4 Satralizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Satralizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Satralizumab in 2021
3.5.3 Global Concentration Ratios (CR8) for Satralizumab in 2021
3.6 Satralizumab Market: Overall Company Footprint Analysis
3.6.1 Satralizumab Market: Region Footprint
3.6.2 Satralizumab Market: Company Product Type Footprint
3.6.3 Satralizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Satralizumab Production Value Comparison
4.1.1 United States VS China: Satralizumab Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Satralizumab Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Satralizumab Production Comparison
4.2.1 United States VS China: Satralizumab Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Satralizumab Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Satralizumab Consumption Comparison
4.3.1 United States VS China: Satralizumab Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Satralizumab Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Satralizumab Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Satralizumab in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Satralizumab Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Satralizumab Production by Domestic Manufacturer, (2017-2022)
4.5 China Satralizumab Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Satralizumab in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Satralizumab Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Satralizumab Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Satralizumab Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Satralizumab in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Satralizumab Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Satralizumab Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Satralizumab Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Solution
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Satralizumab Production by Type (2017-2028)
5.3.2 World Satralizumab Production Value by Type (2017-2028)
5.3.3 World Satralizumab Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Satralizumab Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Treating Neuromyelitis Optica
6.2.2 Prevention of Neuromyelitis Optica
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Satralizumab Production by Application (2017-2028)
6.3.2 World Satralizumab Production Value by Application (2017-2028)
6.3.3 World Satralizumab Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Hoffmann La Roche
7.1.1 Hoffmann La Roche Details
7.1.2 Hoffmann La Roche Major Business
7.1.3 Hoffmann La Roche Satralizumab Product and Services
7.1.4 Hoffmann La Roche Satralizumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Hoffmann La Roche Recent Developments/Updates
7.1.6 Hoffmann La Roche Competitive Strengths & Weaknesses
7.2 Genentech Inc.
7.2.1 Genentech Inc. Details
7.2.2 Genentech Inc. Major Business
7.2.3 Genentech Inc. Satralizumab Product and Services
7.2.4 Genentech Inc. Satralizumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Genentech Inc. Recent Developments/Updates
7.2.6 Genentech Inc. Competitive Strengths & Weaknesses
7.3 CHUGAI PHARMACEUTICAL CO.,LTD.
7.3.1 CHUGAI PHARMACEUTICAL CO.,LTD. Details
7.3.2 CHUGAI PHARMACEUTICAL CO.,LTD. Major Business
7.3.3 CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Product and Services
7.3.4 CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 CHUGAI PHARMACEUTICAL CO.,LTD. Recent Developments/Updates
7.3.6 CHUGAI PHARMACEUTICAL CO.,LTD. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Satralizumab and Key Manufacturers
8.2 Satralizumab Manufacturing Costs
8.3 Satralizumab Production Process
8.4 Satralizumab Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Satralizumab Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Satralizumab Typical Distributors
9.3 Satralizumab Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Satralizumab Introduction
1.2 World Satralizumab Supply & Forecast
1.2.1 World Satralizumab Production Value (2017 & 2021 & 2028)
1.2.2 World Satralizumab Production (2017-2028)
1.2.3 World Satralizumab Pricing Trends (2017-2028)
1.3 World Satralizumab Production by Region
1.3.1 World Satralizumab Production Value by Region (2017-2028)
1.3.2 World Satralizumab Production by Region (2017-2028)
1.3.3 World Satralizumab Average Price by Region (2017-2028)
1.3.4 North America Satralizumab Production (2017-2028)
1.3.5 Europe Satralizumab Production (2017-2028)
1.3.6 Japan Satralizumab Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Satralizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Satralizumab Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Satralizumab Demand (2017-2028)
2.2 World Satralizumab Consumption by Region
2.2.1 World Satralizumab Consumption by Region (2017-2022)
2.2.2 World Satralizumab Consumption Forecast by Region (2023-2028)
2.3 United States Satralizumab Consumption (2017-2028)
2.4 China Satralizumab Consumption (2017-2028)
2.5 Europe Satralizumab Consumption (2017-2028)
2.6 Japan Satralizumab Consumption (2017-2028)
2.7 South Korea Satralizumab Consumption (2017-2028)
2.8 ASEAN Satralizumab Consumption (2017-2028)
2.9 India Satralizumab Consumption (2017-2028)
3 WORLD SATRALIZUMAB MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Satralizumab Production Value by Manufacturer (2017-2022)
3.2 World Satralizumab Production by Manufacturer (2017-2022)
3.3 World Satralizumab Average Price by Manufacturer (2017-2022)
3.4 Satralizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Satralizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Satralizumab in 2021
3.5.3 Global Concentration Ratios (CR8) for Satralizumab in 2021
3.6 Satralizumab Market: Overall Company Footprint Analysis
3.6.1 Satralizumab Market: Region Footprint
3.6.2 Satralizumab Market: Company Product Type Footprint
3.6.3 Satralizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Satralizumab Production Value Comparison
4.1.1 United States VS China: Satralizumab Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Satralizumab Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Satralizumab Production Comparison
4.2.1 United States VS China: Satralizumab Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Satralizumab Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Satralizumab Consumption Comparison
4.3.1 United States VS China: Satralizumab Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Satralizumab Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Satralizumab Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Satralizumab in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Satralizumab Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Satralizumab Production by Domestic Manufacturer, (2017-2022)
4.5 China Satralizumab Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Satralizumab in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Satralizumab Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Satralizumab Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Satralizumab Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Satralizumab in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Satralizumab Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Satralizumab Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Satralizumab Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Solution
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Satralizumab Production by Type (2017-2028)
5.3.2 World Satralizumab Production Value by Type (2017-2028)
5.3.3 World Satralizumab Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Satralizumab Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Treating Neuromyelitis Optica
6.2.2 Prevention of Neuromyelitis Optica
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Satralizumab Production by Application (2017-2028)
6.3.2 World Satralizumab Production Value by Application (2017-2028)
6.3.3 World Satralizumab Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Hoffmann La Roche
7.1.1 Hoffmann La Roche Details
7.1.2 Hoffmann La Roche Major Business
7.1.3 Hoffmann La Roche Satralizumab Product and Services
7.1.4 Hoffmann La Roche Satralizumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Hoffmann La Roche Recent Developments/Updates
7.1.6 Hoffmann La Roche Competitive Strengths & Weaknesses
7.2 Genentech Inc.
7.2.1 Genentech Inc. Details
7.2.2 Genentech Inc. Major Business
7.2.3 Genentech Inc. Satralizumab Product and Services
7.2.4 Genentech Inc. Satralizumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Genentech Inc. Recent Developments/Updates
7.2.6 Genentech Inc. Competitive Strengths & Weaknesses
7.3 CHUGAI PHARMACEUTICAL CO.,LTD.
7.3.1 CHUGAI PHARMACEUTICAL CO.,LTD. Details
7.3.2 CHUGAI PHARMACEUTICAL CO.,LTD. Major Business
7.3.3 CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Product and Services
7.3.4 CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 CHUGAI PHARMACEUTICAL CO.,LTD. Recent Developments/Updates
7.3.6 CHUGAI PHARMACEUTICAL CO.,LTD. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Satralizumab and Key Manufacturers
8.2 Satralizumab Manufacturing Costs
8.3 Satralizumab Production Process
8.4 Satralizumab Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Satralizumab Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Satralizumab Typical Distributors
9.3 Satralizumab Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Satralizumab Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Satralizumab Production Value by Region (2017-2022) & (USD Million)
Table 3. World Satralizumab Production Value by Region (2023-2028) & (USD Million)
Table 4. World Satralizumab Production Value Market Share by Region (2017-2022)
Table 5. World Satralizumab Production Value Market Share by Region (2023-2028)
Table 6. World Satralizumab Production by Region (2017-2022) & (K Units)
Table 7. World Satralizumab Production by Region (2023-2028) & (K Units)
Table 8. World Satralizumab Production Market Share by Region (2017-2022)
Table 9. World Satralizumab Production Market Share by Region (2023-2028)
Table 10. World Satralizumab Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Satralizumab Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Satralizumab Major Market Trends
Table 13. World Satralizumab Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Satralizumab Consumption by Region (2017-2022) & (K Units)
Table 15. World Satralizumab Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Satralizumab Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Satralizumab Producers in 2021
Table 18. World Satralizumab Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Satralizumab Producers in 2021
Table 20. World Satralizumab Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Satralizumab Company Evaluation Quadrant
Table 22. World Satralizumab Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Satralizumab Production Site of Key Manufacturer
Table 24. Satralizumab Market: Company Product Type Footprint
Table 25. Satralizumab Market: Company Product Application Footprint
Table 26. Satralizumab Competitive Factors
Table 27. Satralizumab New Entrant and Capacity Expansion Plans
Table 28. Satralizumab Mergers & Acquisitions Activity
Table 29. United States VS China Satralizumab Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Satralizumab Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Satralizumab Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Satralizumab in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Satralizumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Satralizumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Satralizumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Satralizumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Satralizumab in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Satralizumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Satralizumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Satralizumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Satralizumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Satralizumab in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Satralizumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Satralizumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Satralizumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Satralizumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Satralizumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Satralizumab Production by Type (2017-2022) & (K Units)
Table 49. World Satralizumab Production by Type (2023-2028) & (K Units)
Table 50. World Satralizumab Production Value by Type (2017-2022) & (USD Million)
Table 51. World Satralizumab Production Value by Type (2023-2028) & (USD Million)
Table 52. World Satralizumab Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Satralizumab Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Satralizumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Satralizumab Production by Application (2017-2022) & (K Units)
Table 56. World Satralizumab Production by Application (2023-2028) & (K Units)
Table 57. World Satralizumab Production Value by Application (2017-2022) & (USD Million)
Table 58. World Satralizumab Production Value by Application (2023-2028) & (USD Million)
Table 59. World Satralizumab Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Satralizumab Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Hoffmann La Roche Basic Information, Manufacturing Base and Competitors
Table 62. Hoffmann La Roche Major Business
Table 63. Hoffmann La Roche Satralizumab Product and Services
Table 64. Hoffmann La Roche Satralizumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Hoffmann La Roche Recent Developments/Updates
Table 66. Hoffmann La Roche Competitive Strengths & Weaknesses
Table 67. Genentech Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Genentech Inc. Major Business
Table 69. Genentech Inc. Satralizumab Product and Services
Table 70. Genentech Inc. Satralizumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Genentech Inc. Recent Developments/Updates
Table 72. CHUGAI PHARMACEUTICAL CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 73. CHUGAI PHARMACEUTICAL CO.,LTD. Major Business
Table 74. CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Product and Services
Table 75. CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 76. Satralizumab Raw Material
Table 77. Key Manufacturers of Satralizumab Raw Materials
Table 78. Satralizumab Typical Distributors
Table 79. Satralizumab Typical Customers
Table 1. World Satralizumab Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Satralizumab Production Value by Region (2017-2022) & (USD Million)
Table 3. World Satralizumab Production Value by Region (2023-2028) & (USD Million)
Table 4. World Satralizumab Production Value Market Share by Region (2017-2022)
Table 5. World Satralizumab Production Value Market Share by Region (2023-2028)
Table 6. World Satralizumab Production by Region (2017-2022) & (K Units)
Table 7. World Satralizumab Production by Region (2023-2028) & (K Units)
Table 8. World Satralizumab Production Market Share by Region (2017-2022)
Table 9. World Satralizumab Production Market Share by Region (2023-2028)
Table 10. World Satralizumab Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Satralizumab Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Satralizumab Major Market Trends
Table 13. World Satralizumab Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Satralizumab Consumption by Region (2017-2022) & (K Units)
Table 15. World Satralizumab Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Satralizumab Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Satralizumab Producers in 2021
Table 18. World Satralizumab Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Satralizumab Producers in 2021
Table 20. World Satralizumab Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Satralizumab Company Evaluation Quadrant
Table 22. World Satralizumab Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Satralizumab Production Site of Key Manufacturer
Table 24. Satralizumab Market: Company Product Type Footprint
Table 25. Satralizumab Market: Company Product Application Footprint
Table 26. Satralizumab Competitive Factors
Table 27. Satralizumab New Entrant and Capacity Expansion Plans
Table 28. Satralizumab Mergers & Acquisitions Activity
Table 29. United States VS China Satralizumab Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Satralizumab Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Satralizumab Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Satralizumab in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Satralizumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Satralizumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Satralizumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Satralizumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Satralizumab in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Satralizumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Satralizumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Satralizumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Satralizumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Satralizumab in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Satralizumab Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Satralizumab Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Satralizumab Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Satralizumab Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Satralizumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Satralizumab Production by Type (2017-2022) & (K Units)
Table 49. World Satralizumab Production by Type (2023-2028) & (K Units)
Table 50. World Satralizumab Production Value by Type (2017-2022) & (USD Million)
Table 51. World Satralizumab Production Value by Type (2023-2028) & (USD Million)
Table 52. World Satralizumab Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Satralizumab Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Satralizumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Satralizumab Production by Application (2017-2022) & (K Units)
Table 56. World Satralizumab Production by Application (2023-2028) & (K Units)
Table 57. World Satralizumab Production Value by Application (2017-2022) & (USD Million)
Table 58. World Satralizumab Production Value by Application (2023-2028) & (USD Million)
Table 59. World Satralizumab Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Satralizumab Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Hoffmann La Roche Basic Information, Manufacturing Base and Competitors
Table 62. Hoffmann La Roche Major Business
Table 63. Hoffmann La Roche Satralizumab Product and Services
Table 64. Hoffmann La Roche Satralizumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Hoffmann La Roche Recent Developments/Updates
Table 66. Hoffmann La Roche Competitive Strengths & Weaknesses
Table 67. Genentech Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Genentech Inc. Major Business
Table 69. Genentech Inc. Satralizumab Product and Services
Table 70. Genentech Inc. Satralizumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Genentech Inc. Recent Developments/Updates
Table 72. CHUGAI PHARMACEUTICAL CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 73. CHUGAI PHARMACEUTICAL CO.,LTD. Major Business
Table 74. CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Product and Services
Table 75. CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 76. Satralizumab Raw Material
Table 77. Key Manufacturers of Satralizumab Raw Materials
Table 78. Satralizumab Typical Distributors
Table 79. Satralizumab Typical Customers
LIST OF FIGURES
Figure 1. Satralizumab Picture
Figure 2. World Satralizumab Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Satralizumab Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Satralizumab Production (2017-2028) & (K Units)
Figure 5. World Satralizumab Average Price (2017-2028) & (US$/Unit)
Figure 6. World Satralizumab Production Value Market Share by Region (2017-2028)
Figure 7. World Satralizumab Production Market Share by Region (2017-2028)
Figure 8. North America Satralizumab Production (2017-2028) & (K Units)
Figure 9. Europe Satralizumab Production (2017-2028) & (K Units)
Figure 10. Japan Satralizumab Production (2017-2028) & (K Units)
Figure 11. Satralizumab Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Satralizumab Demand (2017-2028) & (K Units)
Figure 14. World Satralizumab Consumption Market Share by Region (2017-2028)
Figure 15. United States Satralizumab Consumption (2017-2028) & (K Units)
Figure 16. China Satralizumab Consumption (2017-2028) & (K Units)
Figure 17. Europe Satralizumab Consumption (2017-2028) & (K Units)
Figure 18. Japan Satralizumab Consumption (2017-2028) & (K Units)
Figure 19. South Korea Satralizumab Consumption (2017-2028) & (K Units)
Figure 20. ASEAN Satralizumab Consumption (2017-2028) & (K Units)
Figure 21. India Satralizumab Consumption (2017-2028) & (K Units)
Figure 22. Producer Shipments of Satralizumab by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 23. Global Four-firm Concentration Ratios (CR4) for Satralizumab Markets in 2021
Figure 24. Global Four-firm Concentration Ratios (CR8) for Satralizumab Markets in 2021
Figure 25. United States VS China: Satralizumab Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 26. United States VS China: Satralizumab Production Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Satralizumab Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 28. Key Producers and Market Share of Satralizumab in United States
Figure 29. Key Producers and Market Share of Satralizumab in China
Figure 30. Key Producers and Market Share of Satralizumab in Rest of World
Figure 31. World Satralizumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 32. World Satralizumab Production Value Market Share by Type in 2021
Figure 33. Solution
Figure 34. Injection
Figure 35. World Satralizumab Production Market Share by Type (2017-2028)
Figure 36. World Satralizumab Production Value Market Share by Type (2017-2028)
Figure 37. World Satralizumab Average Price by Type (2017-2028) & (US$/Unit)
Figure 38. World Satralizumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 39. World Satralizumab Production Value Market Share by Application in 2021
Figure 40. Treating Neuromyelitis Optica
Figure 41. Prevention of Neuromyelitis Optica
Figure 42. Others
Figure 43. World Satralizumab Production Market Share by Application (2017-2028)
Figure 44. World Satralizumab Production Value Market Share by Application (2017-2028)
Figure 45. World Satralizumab Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Satralizumab in 2021
Figure 47. Manufacturing Process Analysis of Satralizumab
Figure 48. Satralizumab Industrial Chain
Figure 49. Distribution Channel Breakdown for Satralizumab Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Satralizumab Picture
Figure 2. World Satralizumab Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Satralizumab Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Satralizumab Production (2017-2028) & (K Units)
Figure 5. World Satralizumab Average Price (2017-2028) & (US$/Unit)
Figure 6. World Satralizumab Production Value Market Share by Region (2017-2028)
Figure 7. World Satralizumab Production Market Share by Region (2017-2028)
Figure 8. North America Satralizumab Production (2017-2028) & (K Units)
Figure 9. Europe Satralizumab Production (2017-2028) & (K Units)
Figure 10. Japan Satralizumab Production (2017-2028) & (K Units)
Figure 11. Satralizumab Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Satralizumab Demand (2017-2028) & (K Units)
Figure 14. World Satralizumab Consumption Market Share by Region (2017-2028)
Figure 15. United States Satralizumab Consumption (2017-2028) & (K Units)
Figure 16. China Satralizumab Consumption (2017-2028) & (K Units)
Figure 17. Europe Satralizumab Consumption (2017-2028) & (K Units)
Figure 18. Japan Satralizumab Consumption (2017-2028) & (K Units)
Figure 19. South Korea Satralizumab Consumption (2017-2028) & (K Units)
Figure 20. ASEAN Satralizumab Consumption (2017-2028) & (K Units)
Figure 21. India Satralizumab Consumption (2017-2028) & (K Units)
Figure 22. Producer Shipments of Satralizumab by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 23. Global Four-firm Concentration Ratios (CR4) for Satralizumab Markets in 2021
Figure 24. Global Four-firm Concentration Ratios (CR8) for Satralizumab Markets in 2021
Figure 25. United States VS China: Satralizumab Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 26. United States VS China: Satralizumab Production Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Satralizumab Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 28. Key Producers and Market Share of Satralizumab in United States
Figure 29. Key Producers and Market Share of Satralizumab in China
Figure 30. Key Producers and Market Share of Satralizumab in Rest of World
Figure 31. World Satralizumab Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 32. World Satralizumab Production Value Market Share by Type in 2021
Figure 33. Solution
Figure 34. Injection
Figure 35. World Satralizumab Production Market Share by Type (2017-2028)
Figure 36. World Satralizumab Production Value Market Share by Type (2017-2028)
Figure 37. World Satralizumab Average Price by Type (2017-2028) & (US$/Unit)
Figure 38. World Satralizumab Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 39. World Satralizumab Production Value Market Share by Application in 2021
Figure 40. Treating Neuromyelitis Optica
Figure 41. Prevention of Neuromyelitis Optica
Figure 42. Others
Figure 43. World Satralizumab Production Market Share by Application (2017-2028)
Figure 44. World Satralizumab Production Value Market Share by Application (2017-2028)
Figure 45. World Satralizumab Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Satralizumab in 2021
Figure 47. Manufacturing Process Analysis of Satralizumab
Figure 48. Satralizumab Industrial Chain
Figure 49. Distribution Channel Breakdown for Satralizumab Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
